Noxxon publishes annual general meetings documents

(PresseBox) ( Berlin, )
NOXXON Pharma N.V. (Alternext Paris: ALNOX), a biotechnology company whose core focus is on improving cancer treatment by targeting the tumor microenvironment, announced today that the annual general meeting of shareholders (AGM) is convened at 13.30 hours (CET) on June 27, 2017 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.

The 2016 annual statutory accounts including the annual report, a formal notice convening the AGM, the agenda of the AGM, the explanatory notes to the agenda, the instructions to participate and vote at the AGM, and other AGM documents have now been published on the Company's website (

These documents will also be available at the company's offices at Max-Dohrn-Straße 8-10, 10589 Berlin, Germany, for shareholders and persons entitled to attend the meeting who, upon request, will receive a copy free of charge.

The board of directors has decided that it will apply a registration date for the determination of the persons entitled to attend and to vote at the AGM, which date is the 28th day prior to the AGM pursuant to Dutch law. To be eligible to attend and to vote at the AGM, persons must be registered as shareholder in one of the administration records of the intermediaries that are (indirectly) participants in Euroclear France on May 30, 2017 (the “Registration Date”) after all debit and credit entries have been handled as per the Registration Date.


Certain statements in this communication contain formulations or terms referring to the future or future developments, as well as negations of such formulations or terms, or similar terminology. These are described as forward-looking statements. In addition, all information in this communication regarding planned or future results of business segments, financial indicators, developments of the financial situation or other financial or statistical data contains such forward-looking statements. The company cautions prospective investors not to rely on such forward-looking statements as certain prognoses of actual future events and developments. The company is neither responsible nor liable for updating such information, which only represents the state of affairs on the day of publication.
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an